Done sou Salè H1B

Akèy › Anplwayè › Boehringer Ingelheim Pharmaceuticals, Inc. › Principal Scientist

Principal Scientist nan Boehringer Ingelheim Pharmaceuticals, Inc.: Salè H-1B

5 aplikasyon kondisyon travay pou tit travay Principal Scientist nan Boehringer Ingelheim Pharmaceuticals, Inc.. Salè baz medyàn ofri $155,000; mwatye mitan $141,846–$172,095.

Demann (LCA)5
Salè medyan ofri$155,000
Mwatye salè yo$141,846–$172,095
10yèm–90yèm pousantaj$140,035–$178,923

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20231$138,828
FY20242$148,423
FY20251$183,475
FY20261$172,095

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$172,095
Nivo III
Ridgefield, CTJun 15, 2026Oct 1, 2026Certifye
$183,475
Nivo IV
Ridgefield, CTJun 12, 2025Oct 1, 2025Certifye
$155,000
Nivo IV
Ridgefield, CTJun 4, 2024Oct 1, 2024Certifye
$141,846
Nivo III
Ridgefield, CTMar 14, 2024Sep 1, 2024Certifye
$138,828–$165,235
Nivo III
Ridgefield, CTApr 12, 2023Aug 12, 2023Certifye

Principal Scientist nan tout anplwayè yo →

Lòt travay nan Boehringer Ingelheim Pharmaceuticals, Inc.

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).